
Amanda G. Lewis
About
Ms. Lewis was one of the primary authors of the Majority Staff Report and Recommendations and helped draft the bills currently making their way through Congress to rein in Big Tech. In addition, Ms. Lewis took the lead on health care for the Subcommittee, overseeing several hearings related to competition in the healthcare sector and a successful, bipartisan markup of four healthcare antitrust bills, resulting in all four bills being reported out of Committee on a unanimous, bipartisan basis and the enactment of two bills into law, including the CREATES Act and the Competitive Health Insurance Reform Act.
At the FTC, as an attorney in the Mergers IV division, Ms. Lewis worked on the Staples/Office Depot and Sysco/U.S. Foods litigation teams, as well as numerous other merger and conduct investigations.
Prior to the FTC, Ms. Lewis was an associate at Cravath, Swaine & Moore and a law clerk for Judge Lawrence McKenna of the Southern District of New York. She received her B.A. from New York University in 2002 and her J.D. from Columbia Law School in 2008.
EDUCATION
- Columbia University School of Law J.D., May 2008, Harlan Fiske Stone Scholar
- New York University B.A., summa cum laude, Sept. 2002, in Political Science and Latin American Studies
SUBSTANTIVE PRACTICE AREAS
- Antitrust
- Consumer Protection
- Digital Markets
- Health Care
- Litigation
- Government Affairs
- Third-Party Merger and Non-Merger Antitrust Representation
BAR ADMISSIONS
- New York
COURT ADMISSIONS
- United States District Court for the Southern District of New York
- Second Circuit Court of Appeals and S.D.N.Y.
- United States Court of Appeals for the Second Circuit
Associations & Memberships
- Member, Policy Task Force, COSAL (2022-Present)
- Co-Chair, U.S. Comments and Policy Committee, Section of Antitrust Law, American Bar Association (2022-Present)
- Vice Chair, Health Care and Pharmaceuticals Committee, Section of Antitrust Law, American Bar Association (2017-2022)
- Member, Biden Health Policy Committee, Subcommittee on Cost Containment; voluntary role designated by the Biden for President Campaign (Summer 2020)
In The News
- Amanda Lewis Quoted in ‘Inside US Trade’
- January 11th, 2024
- Amanda Lewis On Bloomberg Markets Close: FTC Sues Amazon
- September 26th, 2023
- Amanda Lewis’ Senate testimony quoted in Politico
- March 20th, 2023
Other Articles
- GCR – Big Tech foe to leave Congress
- Feb 2023
- POLITICO – All Tomorrow’s Monopolies
- Sept 2022
- Press Release – Amanda Lewis Joins CGL
- Sept 2022
- Bloomberg – Amazon’s iRobot Deal Seen Facing Tough FTC Antitrust Review
- Aug 2022
- FTC Watch – People – Amanda Lewis Joins CGL
- Jul. 2022
- Digital Future Daily, Politico – Transitions highlighting Statement From Subcommittee Chair David Cicilline
- Sept. 2021
- Protocol.com – A tiny team of House staffers could change the future of Big Tech
- Oct. 2020
Publications and Speaking Engagements
- Editor – Judging Big Tech, The Washington Center for Equitable Growth (Dec. 2022)
- The Federalist Society – Biden’s Antitrust Agenda: Mission Creep or Mission Achieved? (Jul. 2022)
- IPLeadership – LeadershIP DMA Virtual Event: EU DMA vs. US Legislative Proposals: Lessons and Path Forward (Jun. 2022)
- ABA Panel – From Investigation to Litigation – Practical Skills for Handling Pharma Matters and Beyond (Jun. 2022)
- ABA Antitrust in Healthcare Virtual Conference – Antitrust Legislation: New Powers for State and Federal Enforcers(Feb. 2021)
- NYIPLA Presidents’ Forum, States Rights: Should States Legislate Intellectual Property in the Pharmaceutical Sector? ( Dec. 2020)
- AAI Pharmaceutical Markets – Competition Roundtable American Antitrust Institute (Sept. 2019)
- Executive Editor, Health Care Chronicle, Section of Antitrust Law, American Bar Association (2014-2022)